[go: up one dir, main page]

SK164297A3 - 1,6-disubstituted isochromans for treatment of migraine headaches - Google Patents

1,6-disubstituted isochromans for treatment of migraine headaches Download PDF

Info

Publication number
SK164297A3
SK164297A3 SK1642-97A SK164297A SK164297A3 SK 164297 A3 SK164297 A3 SK 164297A3 SK 164297 A SK164297 A SK 164297A SK 164297 A3 SK164297 A3 SK 164297A3
Authority
SK
Slovakia
Prior art keywords
ethyl
defined above
isochroman
alkyl
piperazinyl
Prior art date
Application number
SK1642-97A
Other languages
English (en)
Slovak (sk)
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SK164297A3 publication Critical patent/SK164297A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1642-97A 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches SK164297A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (1)

Publication Number Publication Date
SK164297A3 true SK164297A3 (en) 1998-09-09

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1642-97A SK164297A3 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Country Status (12)

Country Link
EP (1) EP0836599A1 (es)
JP (1) JPH11509532A (es)
AU (1) AU6252296A (es)
BR (1) BR9609631A (es)
CA (1) CA2225282A1 (es)
CZ (1) CZ418597A3 (es)
FI (1) FI974640L (es)
MX (1) MX9710260A (es)
NO (1) NO976112L (es)
PL (1) PL324319A1 (es)
SK (1) SK164297A3 (es)
WO (1) WO1997002259A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (pt) 2004-05-05 2007-11-20 Hoffmann La Roche arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos
CN101119989B (zh) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 色满衍生物及其在治疗cns疾病中的用途
AU2005318596B2 (en) 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ES2314749T3 (es) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag Derivados de tetralina y de indano y usos de los mismos como antagonistas de 5-ht.
KR100899061B1 (ko) 2004-12-21 2009-05-25 에프. 호프만-라 로슈 아게 테트랄린 및 인단 유도체 및 이의 용도
PL1831159T3 (pl) 2004-12-21 2010-06-30 Hoffmann La Roche Pochodne tetraliny i indanu oraz ich zastosowania
RU2008115032A (ru) 2005-11-03 2009-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) Арилсульфонилхроманы в качестве ингибиторов 5-нт6
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN102341367B (zh) * 2009-03-05 2014-05-07 住友化学株式会社 卤素取代苯二甲醇的制造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
MX9710260A (es) 1998-03-29
NO976112D0 (no) 1997-12-29
FI974640A7 (fi) 1997-12-30
CZ418597A3 (cs) 1998-06-17
WO1997002259A1 (en) 1997-01-23
FI974640A0 (fi) 1997-12-30
FI974640L (fi) 1997-12-30
BR9609631A (pt) 1999-03-02
AU6252296A (en) 1997-02-05
CA2225282A1 (en) 1997-01-23
NO976112L (no) 1998-03-02
EP0836599A1 (en) 1998-04-22
PL324319A1 (en) 1998-05-25
JPH11509532A (ja) 1999-08-24

Similar Documents

Publication Publication Date Title
US7456164B2 (en) 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
AU2013254657B2 (en) Novel compounds
US7951821B2 (en) N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
US6498168B2 (en) Muscarinic antagonists
EP1951660B1 (en) Histamine-3 receptor antagonists
TW536537B (en) Benzoxazine antimicrobial agents
US6436928B1 (en) Selective neurokinin antagonists
JP5189110B2 (ja) ドーパミンd4受容体拮抗剤であるピペラジニル−プロピル−ピラゾール誘導体及びそれを含む医薬組成物
SK164297A3 (en) 1,6-disubstituted isochromans for treatment of migraine headaches
NL1028968C2 (nl) 3- of 4-monogesubstitueerde fenol- en thiofenolderivaten die als H3-liganden bruikbaar zijn.
US20090124624A1 (en) Substituted 1-aminophthalazine derivatives, preparation thereof and therapeutic application thereof
JPWO2005037269A1 (ja) 新規ピペリジン誘導体
WO2003089411A1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique
JP2001525406A (ja) 新規な化合物
JP5250627B2 (ja) 新規化合物
US7122677B2 (en) NK1 antagonists
US7649002B2 (en) (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US10017480B2 (en) Compounds having a selective PDE4D inhibiting activity
EP3055293A1 (en) Diarylalkylamine rev-erb antagonists and their use as medicaments
HU225747B1 (en) New benzenesulphonamide compounds, their preparation thereof and pharmaceutical compositions containing them
CN101300226B (zh) 对组蛋白脱乙酰酶具有抑制活性的烷基氨甲酰基萘氧基辛烯酰基羟基酰胺衍生物及其制备方法
EP2401268B1 (en) Oxyindole derivatives with motilin receptor agonistic activity
OA11235A (en) Quatenary ammonium compounds as tachykinin antagonists
DE69615696T2 (de) Heterocyclische verbindungen zur behandlung von myokard-ischemia
JPH06306025A (ja) ジアリールアルカン誘導体